Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 43
1
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Do fungi exposed to toxic waste produce novel antimicrobial agents?

We've discovered a few new mushrooms thriving in this harsh environment of land-disposed sewage sludge in...

A Prescription for Health and Fitness Based on Your Genes

Exercise has many health benefits. Yet, most people stop their exercise programs after they start them...

S-glutathionylation reactions in mitochondrial function and disease

This project was an invited review that is currently under minor revision at Frontiers Cellular and Developmental...

Backer Badge Funded